Imkta Surges Ahead Of Key Technical Level 20260401 1 Canadian Biotech Sector Shows Promise in 2026 Industry Report Highlights Boston Sci BSX Delivers Q1 2026 Beat EPS 080 vs 079 Expected Expeditors EXPD Reports Strong Q1 2026 Revenue NA EPS Beats UAEs Exit Does Not Signal OPECs Demise Analysts Suggest SpaceX Scrubs Starship Test Flight Sets New Launch Attempt for Friday Regaal Resources Reports 24 Revenue Growth to 1134 Crore in Fiscal Year 2026 UKGulf Trade Deal Hailed as Monumental Achievement by Bahrains Industry Minister US Consumer Sentiment Remains Gloomy Amid Persistent Inflation Geopolitical Tensions and Trade Policy Uncertainty US April Payrolls Surge Beyond Expectations Yet Red Flags Emerge Goldman Sachs Russias Crude Exports Remain Stable Despite Latest US Sanctions BMNR Q1 2026 Earnings Positive EPS Surprise Amidst Modest Operational Disclosure ABEO Q1 2026 Earnings Narrowing Losses as Biotech Advances Pipeline SEE Q4 2025 Earnings EPS Surpasses Estimates by 43 Revenue Details Remain Undisclosed VSAT Q1 2026 Earnings Strong EPS Surprise Drives Shares Higher Cheniere Energy Q1 2026 Earnings Massive EPS Miss Driven by NonCash Charges Stock Holds Steady SES AI Corporation Q1 2026 Earnings EPS Misses Estimates Amid Continued PreRevenue Phase Foremost Clean Energy FMST Dips Nearly 3 Key Support Level in Focus Puma Biotechnology PBYI Edges Higher Amidst Key Support and Resistance Levels Quad Graphics QUAD Shares Rise on AboveAverage Volume Key Levels in Focus Akso Health Group AHG Climbs 132 Navigating Support and Resistance Levels GSI Technology GSIT Surges 474 as Momentum Builds Near Key Resistance SELLAS Life Sciences Group SLS Surges 629 as Biotech Momentum Builds IVDAW Warrants Remain Static at 003 as Trading Activity Remains Subdued Alpine Income Property Trust PINE Gains 15 Approaches Key Resistance at 2056 Talkspace TALK Holds Steady Near Key Support Level Greenwich LifeSciences GLSI Slips 094 as Stock Hovers Near Key Support Roundhill Memory ETF Surges to Record 98 Billion as AIDriven Demand Fuels Chip Bottleneck AMBR Q4 2025 Earnings EPS Misses Estimates by Narrow Margin Shares Decline Corbus Pharmaceuticals CRBP Slides 14 as Key Support Level Comes into Focus